WallStreetZenWallStreetZen

NYSE: JNJ
Johnson & Johnson Earnings & Revenue

OverviewForecastEarnings
DividendOwnershipStatistics

JNJ past earnings growth

How has JNJ's earnings growth performed historically?
Company
7.51%
Industry
39.51%
Market
40.4%
JNJ's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
JNJ's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
JNJ's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

JNJ past revenue growth

How has JNJ's revenue growth performed historically?
Company
5.02%
Industry
12.36%
Market
154.86%
JNJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
JNJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
JNJ's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

JNJ earnings and revenue history

Current Revenue
$96.0B
Current Earnings
$19.2B
Current Profit Margin
19.9%
JNJ's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

JNJ Return on Equity

Current Company
25.6%
Current Industry
48.8%
Current Market
-8.3%
JNJ's Return on Equity (25.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when JNJ announces earnings.

JNJ Return on Assets

Current Company
10.7%
Current Industry
11.3%
JNJ is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

JNJ Return on Capital Employed

Current Company
17.38%
Current Industry
17.8%
JNJ has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

JNJ vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
JNJ$96.04B$29.56B$19.16B+5.25%+4.53%
LLY$29.24B$8.14B$6.03B+5.41%+25.80%
MRK$58.97B$20.62B$15.26B+8.18%+42.12%
ABBV$57.82B$25.20B$13.41B+16.22%+12.65%
PFE$99.68B$38.03B$29.77B+13.69%+26.49%
View Top General Drug Manufacturer Stocks

Johnson & Johnson Earnings & Revenue FAQ

What were JNJ's earnings last quarter?

On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q3 2022 earnings per share (EPS) of $1.70, up 22.3% year over year. Total Johnson & Johnson earnings for the quarter were $4.46 billion. In the same quarter last year, Johnson & Johnson's earnings per share (EPS) was $1.39.

If you're new to stock investing, here's how to buy Johnson & Johnson stock.

What was JNJ's earnings growth in the past year?

As of Q1 2023, Johnson & Johnson's earnings has grown 7.51% year over year. This is 32 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 39.51%. Johnson & Johnson's earnings in the past year totalled $19.16 billion.

What was JNJ's revenue last quarter?

On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q3 2022 revenue of $23.79 billion up 1.94% year over year. In the same quarter last year, Johnson & Johnson's revenue was $23.34 billion.

What was JNJ's revenue growth in the past year?

As of Q1 2023, Johnson & Johnson's revenue has grown 5.02% year over year. This is 7.34 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.36%. Johnson & Johnson's revenue in the past year totalled $96.04 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.